RapidTEG MA Validation

计划入组 17 人 · 首次发布于 2011 年 9 月 2 日

MA in tongue trauma

计划入组 90 人

R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma

计划入组 58 人 · 首次发布于 2026 年 8 月 14 日

AZD-4604

MA-0204

MA-2029

Biogen Ma Inc.

United States

BIOGEN MA INC

United States

Pfizer Europe MA EEIG

United Kingdom

Maipl Therapeutics and Endosure Form Alliance to Accelerate Non-Hormonal Endometriosis Treatment Development

First Oral Drug MA-5 Shows Promise for Rare Barth Syndrome in Preclinical Studies

Chelsea, MA Launches Citywide Mental Health Campaign for Youth Wellbeing